ImmunityBio, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – IBRX
LOS ANGELES–(BUSINESS WIRE)–$IBRX—The DJS Law Group reminds investors of a class action lawsuit against ImmunityBio, Inc. (“ImmunityBio” or... Read more.
SMCI Investors Have Opportunity to Lead Super Micro Computer, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$SMCI—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit... Read more.
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$IBRX—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit... Read more.
WMK Investors Have Opportunity to Join Weis Markets, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$WMK—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims... Read more.
EVTL Investors Have Opportunity to Join Vertical Aerospace Ltd. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$EVTL—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims... Read more.
SAN Investors Have Opportunity to Join Banco Santander, S.A. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$SAN—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims... Read more.
BW Investors Have Opportunity to Join Babcock & Wilcox Enterprises, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$BW—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on... Read more.
Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously Published in JACC
Patients treated with tonlamarsen experienced statistically significant reductions in plasma angiotensinogen levels and clinically meaningful changes in systolic... Read more.
Debevoise Secures Second Circuit Affirmance of Dismissal of $16 billion Claim Against YPF S.A.
NEW YORK–(BUSINESS WIRE)–Debevoise & Plimpton LLP has secured affirmance from the U.S. Court of Appeals for the Second Circuit of its 2023 summary... Read more.
YRD Investors Have Opportunity to Join Yiren Digital Ltd. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$YRD—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims... Read more.